Abstract
On 18q, frequently deleted in late stage colorectal cancers, a gene, Deleted in Colon Cancer (DCC), has been identified and postulated to play a role as a tumor suppressor gene. DCC is retained in the majority of mucinous tumors, which produce high levels of mucins, and seems to be preferentially expressed in intestinal goblet cells. To investigate whether DCC is related to mucin expression and can modulate the transformed phenotype, we introduced a full-length DCC cDNA into HT29 cells, which can be induced in vitro to express MUC2, the gene that encodes the major colonic mucin. Expression of DCC did not modulate constitutive or induced expression of MUC2, nor did DCC induce a mature goblet cell phenotype. However, HT29 clones expressing high and low levels of DCC protein showed a significant decrease in cell proliferation and tumorigenicity. Furthermore, increased shedding and an elevated rate of spontaneous apoptosis were associated with higher levels of expression of DCC. In summary, while restoration of DCC expression in a human colon carcinoma cell line did not influence expression of differentiation markers, DCC expression did affect the growth and tumorigenic properties of the cells suggesting that DCC can modulate the malignant phenotype of colon cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Augenlicht L, Taylor J, Anderson L and Lipkin M. . 1991 Proc. Natl. Acad. Sci. USA 88: 3286–3289.
Bedi A, Pasricha PJ, Akhatar AJ, Barber JP, Bedi JC, Giadiello FM, Zehnbauer BA, Hamilton SR and Jones RJ. . 1995 Cancer Res. 55: 1811–1816.
Bursch W, Paffe S, Putz B, Barthel G and Schulte-Hermann R. . 1990 Carcinogenesis 11: 847–853.
Carethers JM, Hawn JK, Greenson JK, Hitchcock CL and Boland CR. . 1998 Gastroenterology 114: 1188–1195.
Chang S-K, Dohrman A, Basbaum C, Ho S, Tsuda T, Toribara N, Gum J and Kim YS. . 1994 Gastroenterology 107: 28–36.
Chen SS-Y, Zheng H, Su M-W, Wilk R, Killeen MT, Hedgecock EM and Culotti JG. . 1996 Cell 87: 187–195.
Cho KR and Fearon ER. . 1995 Curr. Opin. Genet. Dev. 5: 72–78.
Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, Hedge P, Silverman GA and Vogelstein B. . 1994 Genomics 19: 525–531.
Colony P. . 1989 In: Cell and molecular biology of colon cancer. L. Augenlicht (ed.) CRC Press: Boca Raton, Florida pp.1–25.
Colony P and Neutra M. . 1983 Dev. Biol. 97: 349–363.
Derynck R, Gelbart WM, Harland RM, Heldin C-H, Kern SE, Massague J, Melton DA, Mlodzick M, Padgett RW, Roberts AB, Smith J, Thomsen GH, Vogelstein B and Wang X-F. . 1996 Cell 87: 173.
Eppert K, Scherer SW, Ozcelik K, Pirone R, Hoodless P, Kim H, Tsue L, Bapat B, Gallinger S, Andrulis IL, Thompsen GH, Wrana JL and Attisano L. . 1996 Cell 86: 543–552.
Fazell A, Dickinson SL, Hermiston ML, Tighe RB, Steen RG, Small CG, Stoeckli ET, Keino-Masu K, Masu M, Rayburn H, Simons J, Bronson RT, Gordon JI, Tessier-Lavigne M and Weinberg RA. . 1997 Nature 386: 796–804.
Fearon ER. . 1996 Biochem. Biophys. Acta 1288: M17–M23.
Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW and Vogelstein B. . 1990 Science 247: 49–56.
Fearon ER and Vogelstein B. . 1990 Cell 61: 759–767.
Gendler SJ and Spicer AP. . 1995 Ann. Rev. Physiol. 57: 607–634.
Gotley DC, Reeder J, Fawcett J, Walsh M, Bates P, Simmons D and Antalis T. . 1996 Oncogene 13: 787–795.
Gum J, Hicks J, Toribara N, Siddiki B and Kim YS. . 1994 J. Biol. Chem. 269: 2440–2446.
Hahn SA, Schutte M, Shamsul Hoque ATM, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fisher A, Yeo CJ, Hruban RH and Kern SE. . 1996 Science 271: 350–353.
Hedrick L, Cho KR, Fearon ER, Wu TC, Kinzler KW and Vogelstein B. . 1994 Genes Dev. 8: 1174–1183.
Heerdt B, Houston M and Augenlicht L. . 1994 Cancer Res. 54: 3288–3294.
Heerdt B, Houston M, Rediske J and Augenlicht L. . 1996 Cell Growth & Diff. 7: 101–106.
Itoh F, Hinoda Y, Ohe M, Ohe Y, Ban T, Endo T, Imai K and Yachi A. . 1993 Int. J. Cancer 53: 260–263.
Jen J, Kim H, Piantadosi S, Liu Z, Levitt RC, Sistonen P, Kinzler KW, Vogelstein B and Hamilton SR. . 1994 N. Engl. J. Med. 331: 213–221.
Keino-Masu K, Masu M, Hinck L, Leonardo ED, Chan S S-Y, Culotti JG and Tesier-Lavigne M. . 1996 Cell 87: 175–185.
Kim H, Roth KA, Moser AR and Gordon JI. . 1993 J. Cell Biol. 123: 877–893.
Klingelhutz AJ, Hedrick L, Cho KR and McDougal JK. . 1995 Oncogene 10: 1581–1586.
Kolodziej PA, Timpe LC, Mitchell KJ, Fried SR, Goodman CS, Jan LY and Jan YN. . 1996 Cell 87: 197–204.
Laboisse C. . 1989 In: Cell and molecular biology of colon cancer. L. Augenlicht (ed.) CRC Press: Boca Raton. pp.28–43.
Martinez-Lopez E, Abad A, Font A, Monzo M, Ojanguren I, Pifarre A, Sanchez JJ, Martin C and Rossell R. . 1998 Gastroenterology 114: 1180–1187.
Mehelen P, Rabizadeh S, Snipas S, Assa-Munt N, Salvesen G and Bredesen D. . 1998 Nature 395: 801–804.
Moser AR, Pitot HC and Dove WF. . 1990 Science 247: 322–324.
Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C. . 1991 J. Immunol. Meth. 139: 271–279.
Ookawa K, Sakamoto M, Hirohashi S, Yoshida Y, Sugimura T, Terada M and Yokota J. . 1993 Int. J. Cancer 53: 382–387.
Pierceall WE, Cho KR, Getzenberg RH, Reale MA, Hedrick L, Vogelstein B and Fearon ER. . 1994 J. Cell. Biol. 124: 1017–1027.
Reale MA, Hu G, Zafer AL, Getzemberg RH, Levine SM and Fearson ER. . 1994 Cancer Res. 54: 4493–4501.
Reale MA, Reyes-Mugica M, Pierceall WE, Rubinstein MC, Hedrick L, Cohn SL, Nakagawara A, Brodeur GM and Fearon ER. . 1996 Cancer Res. 2: 1097–1102.
Reyes-Mugica M, Rieger-Christ K, Ohgaki H, Ekstrand BC, Helie M, Kleinman G, Yahanda A, Fearon ER, Kleihues P and Reale MA. . 1997 Cancer Res. 382–386.
Reyes-Mugica M, Lin P, Yokota J and Reale M. . 1998 Laboratory Invest. 78: 669–675.
Riefer-Christ KM, Brierly KL and Reale MA. . 1997 Front Biosci. 15: 438–448.
Riggins GJ, Thiagalingam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton S, Wilson JK, Markowitz SD, Kinzler KW and Vogelstein B. . 1996 Nature Genet. 13: 347–349.
Schaeffer, WI and Friend K. . 1976 Cancer Lett. 1: 259–262.
Shibata D, Reale MA, Lavin P, Silverman M, Fearon ER, Steele G, Jessup JM, Loda M and Summerhayes IC. . 1996 N. Engl. J. Med. 335: 1727–1732.
Shoemaker AR, Luongo C, Moser AR, Marton LJ and Dove NF. . 1997 Cancer Res. 57: 1999–2006.
Smits R, Kartheuser A, Jagmohan-Changur S, Leblanc V, Breukel C, de Vries A, van Kranen H, van Krieken JH, Williamson S, Edelman W, Kucherlapati R, Khan PM and Fodde R. . 1997 Carcinogenesis 18: 321–327.
Takaku K, Oshima M, Miyoshi M, Matsui M, Seldin M and Taketo M. . 1998 Cell 92: 645–656.
Tanaka K, Oshimura M, Kikuchi R, Seki M, Hayashi T and Miyaki M. . 1991 Nature 349: 340–342.
Thiagalingam S, Langauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JK, Markovitz SA, Hamiltion SR, Kern SE, Kinzler KW and Vogelstein B. . 1996 Nature Genet. 13: 343–346.
Velcich A and Augenlicht L. . 1993 J. Biol. Chem. 268: 13956–13961.
Velcich A, Palumbo L, Jarry A Laboisse C, Racevskis J and Augenlicht L. . 1995 Cell Growth & Diff. 6: 749–757.
Velcich A, Palumbo L, Selleri L, Evans G and Augenlicht L. . 1997 J. Biol. Chem. 272: 7968–7976.
Vielmetter J, Kayyem JF, Roman JM and Dreyer WJ. . 1994 J. Cell. Biol. 127: 2009–2020.
Vogelstein B, Fearon ER, Hamilton S, Kern S, Preisinger AC, Leppert M, Nakamura Y, White S, Smits A and Bos J. . 1988 N. Engl. J. Med. 319: 525–532
Zhang L, Zhou W, Velculescu V, Kern SE, Hruban RH, Hamilton SR, Vogelstein B and Kinzler KW. . 1997 Science 276: 1268–1272.
Zhu Y, Richardson J, Parada L and Graff J. . 1998 Cell 94: 703–714.
Acknowledgements
We thank Dr B Vogelstein for the generous gift of the CMV – DCC expression plasmid, and critical reading of the manuscript. This work was supported by Grants CA-55913, CA-68965 and P30-13330 from the National Cancer Institute.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Velcich, A., Corner, G., Palumbo, L. et al. Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene. Oncogene 18, 2599–2606 (1999). https://doi.org/10.1038/sj.onc.1202610
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202610
Keywords
This article is cited by
-
Selective depletion of tumour suppressors Deleted in Colorectal Cancer (DCC) and neogenin by environmental and endogenous serine proteases: linking diet and cancer
BMC Cancer (2016)
-
Dependence receptors: a new paradigm in cell signaling and cancer therapy
Oncogene (2010)
-
Role of netrin-1 and netrin-1 dependence receptors in colorectal cancers
British Journal of Cancer (2005)
-
Receptors that mediate cellular dependence
Cell Death & Differentiation (2005)
-
Dependence receptors: between life and death
Cellular and Molecular Life Sciences (2004)